Magnetic Resonance Imaging/Transrectal Ultrasonography Fusion Prostate Biopsy Significantly Outperforms Systematic 12-Core Biopsy for Prediction of Total Magnetic Resonance Imaging Tumor Volume in Active Surveillance Patients.
about
Active surveillance and focal therapy for low-intermediate risk prostate cancerDiagnosis and Monitoring of Prostatic Lesions: A Comparison of Three Modalities: Multiparametric MRI, Fusion MRI/Transrectal Ultrasound (TRUS), and Traditional TRUSIntegration of multiparametric MRI into active surveillance of prostate cancer.Magnetic Resonance Imaging-Ultrasound Fusion-Guided Prostate Biopsy: Review of Technology, Techniques, and Outcomes.Optimizing Patient Population for MP-MRI and Fusion Biopsy for Prostate Cancer Detection.A urologist's perspective on prostate cancer imaging: past, present, and future.Risk stratification of prostate cancer: integrating multiparametric MRI, nomograms and biomarkers.Midline lesions of the prostate: role of MRI/TRUS fusion biopsy and implications in Gleason risk stratification.Co-registration of MRI and ultrasound: accuracy of targeting based on radiology-pathology correlationThe characteristics and spatial distributions of initially missed and rebiopsy-detected prostate cancers.Prostatic intraepithelial neoplasia-like ductal prostatic adenocarcinoma: A case suitable for active surveillance?Prostate Cancer Imaging and Biomarkers Guiding Safe Selection of Active Surveillance.Clinically insignificant prostate cancer suitable for active surveillance according to Prostate Cancer Research International: Active surveillance criteria: Utility of PI-RADS v2.What Are We Missing? False-Negative Cancers at Multiparametric MR Imaging of the Prostate.MRI findings guiding selection of active surveillance for prostate cancer: a review of emerging evidence
P2860
Q26773641-E00F6A6F-11C4-4C95-B020-C0433E35C548Q28068102-0458B95F-470E-4EAF-AFEF-B3C53E174573Q30249514-14FB79EB-107A-4166-8A63-3A67FA513F78Q37055000-9A5BF401-859C-4F30-BA5A-6858D03836DCQ38524498-F2758BE5-87BB-4C12-8ECC-27ECE2F5895CQ38823661-2A199724-EA39-4253-A2C1-3E092B6C1043Q38843182-3610017B-3185-4EED-8F5C-EF6A9016C0CFQ38865909-B711F480-7A56-49ED-BC62-2FBC65792217Q39446394-B7BAC71A-C878-4516-8782-4D23DFD495CCQ39861031-FD07CAE5-E057-4774-AAE6-361F8B931D60Q41902458-18C460E0-5150-4432-AF14-76A3EE79439BQ47149516-4BFD2A82-B850-41FD-B62A-44D803E33286Q47681129-D3C6A7C9-9FD8-45F1-ABAA-5F4F37347B87Q47753876-96BE7CB2-F87B-4781-9E48-32B4A0B352A1Q58562086-4604A90B-08A8-42CD-AD7C-DA0FE78AC7AE
P2860
Magnetic Resonance Imaging/Transrectal Ultrasonography Fusion Prostate Biopsy Significantly Outperforms Systematic 12-Core Biopsy for Prediction of Total Magnetic Resonance Imaging Tumor Volume in Active Surveillance Patients.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Magnetic Resonance Imaging/Tra ...... Active Surveillance Patients.
@ast
Magnetic Resonance Imaging/Tra ...... Active Surveillance Patients.
@en
type
label
Magnetic Resonance Imaging/Tra ...... Active Surveillance Patients.
@ast
Magnetic Resonance Imaging/Tra ...... Active Surveillance Patients.
@en
prefLabel
Magnetic Resonance Imaging/Tra ...... Active Surveillance Patients.
@ast
Magnetic Resonance Imaging/Tra ...... Active Surveillance Patients.
@en
P2093
P2860
P50
P356
P1476
Magnetic Resonance Imaging/Tra ...... Active Surveillance Patients.
@en
P2093
Annerleim Walton-Diaz
Arvin K George
Baris Turkbey
Chinonyerem Okoro
Dima Raskolnikov
Howard L Parnes
Jason T Rothwax
Lambros Stamatakis
M Minhaj Siddiqui
P2860
P304
P356
10.1089/END.2015.0027
P577
2015-04-21T00:00:00Z